个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
周三盘中有12只医疗保健类股走势
Gainers
- Biofrontera (NASDAQ:BFRI) shares increased by 160.83% to $6.86 during Wednesday's regular session. The company's market cap stands at $79.5 million.
- Ocuphire Pharma (NASDAQ:OCUP) shares increased by 37.64% to $4.79. As of 12:30 EST, this security is trading at a volume of 71.3 million shares, making up 37734.56% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $82.8 million.
- Biofrontera (NASDAQ:BFRA) shares increased by 21.62% to $4.5. Trading volume for Biofrontera's stock is 399.3K as of 12:30 EST. This is 2847.14% of its average full-day volume over the last 100 days. The company's market cap stands at $127.6 million.
- Aura Biosciences (NASDAQ:AURA) shares rose 17.1% to $21.02. The market value of their outstanding shares is at $597.1 million.
- Beyond Air (NASDAQ:XAIR) stock rose 14.6% to $14.05. As of 12:30 EST, this security is trading at a volume of 426.1K shares, making up 79.78% of its average full-day volume over the last 100 days. The company's market cap stands at $374.2 million.
- Reviva Pharmaceuticals (NASDAQ:RVPH) shares increased by 13.16% to $3.85. As of 12:30 EST, this security is trading at a volume of 165.9K shares, making up 150.12% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $53.7 million.
Losers
- Qualigen Therapeutics (NASDAQ:QLGN) shares fell 31.84% to $1.75 during Wednesday's regular session. Qualigen Therapeutics's stock is trading at a volume of 17.0 million shares as of 12:30 EST. This is 388.88% of its average full-day volume over the last 100 days. The company's market cap stands at $50.8 million.
- Aptevo Therapeutics (NASDAQ:APVO) shares declined by 28.66% to $12.15. Trading volume for Aptevo Therapeutics's stock is 15.6 million as of 12:30 EST. This is 609.1% of its average full-day volume over the last 100 days. The company's market cap stands at $59.5 million.
- Pasithea Therapeutics (NASDAQ:KTTA) stock decreased by 26.8% to $4.1. The company's market cap stands at $54.1 million.
- Petros Pharmaceuticals (NASDAQ:PTPI) stock declined by 25.22% to $1.75. As of 12:30 EST, Petros Pharmaceuticals's stock is trading at a volume of 4.3 million, which is 71.41% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $23.0 million.
- Esperion Therapeutics (NASDAQ:ESPR) stock decreased by 24.26% to $7.59. As of 12:30 EST, Esperion Therapeutics's stock is trading at a volume of 2.9 million, which is 271.28% of its average full-day volume over the last 100 days. The company's market cap stands at $220.6 million.
- Outlook Therapeutics (NASDAQ:OTLK) shares decreased by 21.48% to $1.23. As of 12:30 EST, Outlook Therapeutics's stock is trading at a volume of 8.0 million, which is 868.56% of its average full-day volume over the last 100 days. The company's market cap stands at $214.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Gainers
赢家
- Biofrontera (NASDAQ:BFRI) shares increased by 160.83% to $6.86 during Wednesday's regular session. The company's market cap stands at $79.5 million.
- Ocuphire Pharma (NASDAQ:OCUP) shares increased by 37.64% to $4.79. As of 12:30 EST, this security is trading at a volume of 71.3 million shares, making up 37734.56% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $82.8 million.
- Biofrontera (NASDAQ:BFRA) shares increased by 21.62% to $4.5. Trading volume for Biofrontera's stock is 399.3K as of 12:30 EST. This is 2847.14% of its average full-day volume over the last 100 days. The company's market cap stands at $127.6 million.
- Aura Biosciences (NASDAQ:AURA) shares rose 17.1% to $21.02. The market value of their outstanding shares is at $597.1 million.
- Beyond Air (NASDAQ:XAIR) stock rose 14.6% to $14.05. As of 12:30 EST, this security is trading at a volume of 426.1K shares, making up 79.78% of its average full-day volume over the last 100 days. The company's market cap stands at $374.2 million.
- Reviva Pharmaceuticals (NASDAQ:RVPH) shares increased by 13.16% to $3.85. As of 12:30 EST, this security is trading at a volume of 165.9K shares, making up 150.12% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $53.7 million.
- 生物翅目纳斯达克(Standard Chartered Bank:BFRI)周三例会期间股价上涨160.83%,至6.86美元。该公司的市值为7950万美元。
- 奥克菲尔制药公司(Ocuphire Pharma)纳斯达克(Starbucks:OCUP)股价上涨37.64%,至4.79美元。截至美国东部时间12:30,该证券成交量为7,130万股,占过去100日全天平均成交量的37734.56。他们流通股的市值为8280万美元。
- 生物翅目纳斯达克(Standard Chartered Bank:BFRA)股价上涨21.62%,至4.5美元。截至美国东部时间12:30,Biofrontera的股票成交量为399.3K。这是过去100日平均全天交易量的2847.14%。该公司的市值为1.276亿美元。
- 灵光生物科学纳斯达克(Alipay:AURA)股价上涨17.1%,至21.02美元。他们流通股的市值为5.971亿美元。
- 超越空气纳斯达克(Sequoia Capital:XAir)股价上涨14.6%,至14.05美元。截至美国东部时间12:30,该证券成交量为426.1K股,占其过去100天全天平均成交量的79.78%。该公司市值为3.742亿美元。
- Reviva制药公司纳斯达克(Starbucks:RVPH)股价上涨13.16%,至3.85美元。截至美国东部时间12:30,这只证券的成交量为165.9K股,占其过去100日全天平均成交量的150.12。他们流通股的市值为5370万美元。
Losers
失败者
- Qualigen Therapeutics (NASDAQ:QLGN) shares fell 31.84% to $1.75 during Wednesday's regular session. Qualigen Therapeutics's stock is trading at a volume of 17.0 million shares as of 12:30 EST. This is 388.88% of its average full-day volume over the last 100 days. The company's market cap stands at $50.8 million.
- Aptevo Therapeutics (NASDAQ:APVO) shares declined by 28.66% to $12.15. Trading volume for Aptevo Therapeutics's stock is 15.6 million as of 12:30 EST. This is 609.1% of its average full-day volume over the last 100 days. The company's market cap stands at $59.5 million.
- Pasithea Therapeutics (NASDAQ:KTTA) stock decreased by 26.8% to $4.1. The company's market cap stands at $54.1 million.
- Petros Pharmaceuticals (NASDAQ:PTPI) stock declined by 25.22% to $1.75. As of 12:30 EST, Petros Pharmaceuticals's stock is trading at a volume of 4.3 million, which is 71.41% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $23.0 million.
- Esperion Therapeutics (NASDAQ:ESPR) stock decreased by 24.26% to $7.59. As of 12:30 EST, Esperion Therapeutics's stock is trading at a volume of 2.9 million, which is 271.28% of its average full-day volume over the last 100 days. The company's market cap stands at $220.6 million.
- Outlook Therapeutics (NASDAQ:OTLK) shares decreased by 21.48% to $1.23. As of 12:30 EST, Outlook Therapeutics's stock is trading at a volume of 8.0 million, which is 868.56% of its average full-day volume over the last 100 days. The company's market cap stands at $214.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
- 夸里根治疗公司纳斯达克(Standard Chartered Bank:QLGN)周三例会期间股价下跌31.84%,至1.75美元。截至美国东部时间12:30,Qualigen治疗公司的股票交易量为1700万股。这是过去100日平均全天交易量的388.88%。该公司的市值为5080万美元。
- Aptevo治疗公司纳斯达克(Starbucks:APVO)股价下跌28.66%,至12.15美元。截至美国东部时间12:30,Aptevo Treeutics的股票交易量为1,560万股。这是过去100日平均全天交易量的609.1%。该公司的市值为5950万美元。
- 帕西娅治疗公司(Pasithea Treateutics)纳斯达克(Starbucks:KTTA)股价下跌26.8%,至4.1美元。该公司的市值为5410万美元。
- Petros制药公司纳斯达克(Starbucks:PTPI)股价下跌25.22%,至1.75美元。截至美国东部时间12:30,Petros PharmPharmticals的股票成交量为430万股,是其过去100天全天平均成交量的71.41%。他们流通股的市值为2300万美元。
- Esperion治疗学纳斯达克(Starbucks:ESPR)股价下跌24.26%,至7.59美元。截至美国东部时间12:30,Esperion Treeutics的股票成交量为290万股,是过去100日全天平均成交量的271.28%。该公司的市值为2.206亿美元。
- Outlook治疗公司纳斯达克(Starbucks:OTLK)股价下跌21.48%,至1.23美元。截至美国东部时间12:30,Outlook Treeutics的股票成交量为800万股,是其过去100日全天平均成交量的868.56%。该公司市值为2.147亿美元。另见:Www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!